Lee Jordan
Lee Jordan
Consultant Breast Pathologist, Senior Clinical Lecturer (NHS Tayside/University of Dundee).
Verified email at nhs.net
Title
Cited by
Cited by
Year
Quantitative shear wave ultrasound elastography: initial experience in solid breast masses
A Evans, P Whelehan, K Thomson, D McLean, K Brauer, C Purdie, ...
Breast Cancer Res 12 (6), R104, 2010
4512010
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial
S Hadad, T Iwamoto, L Jordan, C Purdie, S Bray, L Baker, G Jellema, ...
Breast Cancer Research and Treatment 128 (3), 783-794, 2011
3052011
A Pin1/mutant p53 axis promotes aggressiveness in breast cancer
JE Girardini, M Napoli, S Piazza, A Rustighi, C Marotta, E Radaelli, ...
Cancer Cell 20 (1), 79-91, 2011
2702011
A Prospective Comparison of Switches in Biomarker Status between Primary and Recurrent Breast Cancer: The Breast Recurrence in Tissues Study (BRITS)
LB Jordan, CA Purdie, PR Quinlan, E Anderson, AM Thompson, ...
Cancer Research 70 (13), 5642, 2010
256*2010
Invasive breast cancer: relationship between shear-wave elastographic findings and histologic prognostic factors
A Evans, P Whelehan, K Thomson, D McLean, K Brauer, C Purdie, ...
Radiology 263 (3), 673-677, 2012
2382012
Differentiating benign from malignant solid breast masses: value of shear wave elastography according to lesion stiffness combined with greyscale ultrasound according to BI …
A Evans, P Whelehan, K Thomson, K Brauer, L Jordan, C Purdie, ...
British Journal of Cancer 107 (2), 224-229, 2012
2322012
p53 acts as the safeguard of translational control through the regulation of fibrillarin and rRNA methylation in ca
V Marcel, SE Ghayad, S Belin, G Therizols, AP Morel, E Solano-Gonzàlez, ...
Cancer Cell 24 (3), 318-330, 2013
178*2013
CYP2D6 Genotype and Adjuvant Tamoxifen: Meta‐Analysis of Heterogeneous Study Populations
MA Province, MP Goetz, H Brauch, DA Flockhart, JM Hebert, R Whaley, ...
Clinical Pharmacology & Therapeutics 95 (2), 216-227, 2014
1702014
Histological evaluation of AMPK signalling in primary breast cancer
SM Hadad, L Baker, PR Quinlan, KE Robertson, SE Bray, G Thomson, ...
BMC cancer 9 (1), 1-9, 2009
1702009
Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies
E Amir, M Clemons, CA Purdie, N Miller, P Quinlan, W Geddie, ...
Cancer Treatment Reviews 38 (6), 708-714, 2011
1622011
Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study
CA Purdie, P Quinlan, LB Jordan, A Ashfield, S Ogston, JA Dewar, ...
British journal of cancer 110 (3), 565-572, 2014
1412014
DNA polymerase θ up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability
F Lemée, V Bergoglio, A Fernandez-Vidal, A Machado-Silva, MJ Pillaire, ...
Proceedings of the National Academy of Sciences 107 (30), 13390-13395, 2010
1312010
Magnetic resonance imaging texture analysis classification of primary breast cancer
SA Waugh, CA Purdie, LB Jordan, S Vinnicombe, RA Lerski, P Martin, ...
European radiology 26 (2), 322-330, 2016
1282016
A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences
AM Shaaban, GR Ball, RA Brannan, G Cserni, AD Benedetto, J Dent, ...
Breast Cancer Research and Treatment 133 (3), 949-958, 2011
1112011
Therapeutic targeting of integrin αvβ6 in breast cancer
KM Moore, GJ Thomas, SW Duffy, J Warwick, R Gabe, P Chou, IO Ellis, ...
JNCI: Journal of the National Cancer Institute 106 (8), 2014
1062014
p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients
JC Bourdon, MP Khoury, A Diot, L Baker, K Fernandes, M Aoubala, ...
Breast Cancer Research 13 (1), R7, 2011
982011
Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy
AM Thompson, A Johnson, P Quinlan, G Hillman, M Fontecha, SE Bray, ...
Breast Cancer Research and Treatment 125 (1), 279-287, 2011
892011
Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcome
SI King, CA Purdie, SE Bray, PR Quinlan, LB Jordan, AM Thompson, ...
Breast cancer research 14 (2), 1-11, 2012
872012
Does shear wave ultrasound independently predict axillary lymph node metastasis in women with invasive breast cancer?
A Evans, P Rauchhaus, P Whelehan, K Thomson, CA Purdie, LB Jordan, ...
Breast cancer research and treatment 143 (1), 153-157, 2014
852014
Can shear-wave elastography predict response to neoadjuvant chemotherapy in women with invasive breast cancer?
A Evans, S Armstrong, P Whelehan, K Thomson, P Rauchhaus, C Purdie, ...
British journal of cancer 109 (11), 2798-2802, 2013
812013
The system can't perform the operation now. Try again later.
Articles 1–20